BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-119@pharmaconomics
DTSTAMP:20260707T020716Z
DTSTART;VALUE=DATE:20270129
DTEND;VALUE=DATE:20270130
SUMMARY:IDYA Phase 2 — IDE196
DESCRIPTION:Phase 2 trial results for IDE196 in Metastatic Uveal Melanoma are due Jan 29\, 2027. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT03947385\n\nTrack it: https://pharmaconomics.com/e/119
URL:https://pharmaconomics.com/e/119
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:IDYA catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR